hsa-mir-6715a: Hsa-mir-6715a, a novel microRNA (miRNA), was detected in the analysis [PMC4162537]. Although it was not included in miRBase release 18, it was later included in subsequent releases, indicating the reliability of the strategy used to identify novel miRNAs [PMC4162537]. Zhang & Ge (2019) found a relationship between hsa-mir-6715a and cholangiocarcinoma [PMC9248787]. In a study, hsa-mir-6715a was chosen along with hsa-mir-1295b and hsa-mir-33b to build a ceRNA network [PMC6451803]. However, no reports related to cancer and hsa-mir-6715a were identified [PMC6451803]. Hsa-mir-6715a, along with other miRNAs and lncRNAs, were found to be correlated in the study [PMC6451803]. In another analysis, hsa-mir-1266, hsa-mir-1295b, hsa-mir-33b, hsa-mir-551b, and hsa-mir-6715a were identified as prognostic DEmiRNAs in addition to other lncRNAs and mRNAs [PMC6451803]. The study demonstrated that low-expression levels of hsa-miR33b, hasmiR1295b,and hasmiR6715awere associated with poor overall survival (OS) in cholangiocarcinoma patients. These miRNAs were suggested as potential therapeutic targets that require further research [PMC6451803].